These include the translocation t(15;17)(q24.1;q21.2), that leads to the fusion of promyelocytic leukemia (PML) gene with the retinoic acid receptor alpha (RARA), in acute promyelocytic leukemia, which represent ~5% of pediatric AML [9]. The gene discussed is RARA; the disease is acute promyelocytic leukemia.